The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors

Nutrition and Cancer

Volumn 63, Issue 2, 2011, Pages 218-226

  Priyadarsini, Ramamurthi Vidya ^a   Vinothini, Govindarajah ^a   Murugan, Ramalingam Senthil ^a   Manikandan, Palrasu ^a   Nagini, Siddavaram ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE; CYCLIN D1; CYCLINE; CYTOCHROME C; DNA METHYLTRANSFERASE 1; FAS ANTIGEN; FAS LIGAND; FLAVONOID; FLICE INHIBITORY PROTEIN; GLYCOPROTEIN; HISTONE DEACETYLASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; PROTEIN RECK; QUERCETIN; SURVIVIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; EPIGENETICS; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CANCER; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; WESTERN BLOTTING;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CASPASES; CELL PROLIFERATION; CELL SURVIVAL; CHEEK; CRICETINAE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPIGENOMICS; HISTONE DEACETYLASE 1; MALE; MESOCRICETUS; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; QUERCETIN;

CRICETINAE;

EID: 79951915882     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2011.523503     Document Type: Article

References (36)

1. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100, 57-70, 2000. (Pubitemid 30046295)
2. Lopez J, Percharde M, Coley HM, Webb A, and Crook T: The context and potential of epigenetics in oncology. Br J Cancer 100, 571-577, 2009.
3. Goel A, Jhurani S, and Aggarwal BB: Multitargeted therapy by curcumin: how spicy is it? Mol Nutr Food Res 52, 1010-1030, 2008.
4. van Breemen RB and Pajkovic N: Multitargeted therapy of cancer by lycopene. Cancer Lett 269, 339-351, 2008.
5. Khan N and Mukhtar H: Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 269, 269-280, 2008.
6. Murakami A, Ashida H, and Terao J: Multitargeted cancer prevention by quercetin. Cancer Lett 269, 315-325, 2008.
7. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, et al.: Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74, 418-425, 2001. (Pubitemid 32880250)
8. Vásquez-Garzón VR, Arellanes-Robledo J, García-Román R, Aparicio-Rautista DI, and Villa-Treviño S: Inhibition of reactive oxygen species and pre-neoplastic lesions by quercetin through an antioxidant defense mechanism. Free Radic Res 43, 128-137, 2009.
9. Boots AW, Haenen GR, and Bast A: Health effects of quercetin: From antioxidant to nutraceutical. Eur J Pharmacol 585, 325-337, 2008.
10. Siegelin MD, Reuss DE, Habel A, Rami A, and von Deimling A: Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells. Neuro Oncol 11, 122-131, 2009.
11. Shan BE, Wang MX, and Li RQ: Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D(1) and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest 27, 604-612, 2009.
12. Choi EJ, Bae SM, and Ahn WS: Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Arch Pharm Res 31, 1281-1285, 2008.
13. Devipriya S, Ganapathy V, and Shyamaladevi CS: Suppression of tumour growth and invasion in 9,10-dimethylbenz[a]anthracene induced mammary carcinoma by the plant bioflavonoid quercetin. Chem Biol Interact 162, 106-113, 2006. (Pubitemid 44189958)
14. Khanduja KL, Gandhi RK, Pathania V, and Syal N: Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice. Food Chem Toxicol 37, 313-318, 1999. (Pubitemid 29335758)
15. O'Prey J, Brown J, Fleming J, and Harrison PR: Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells. Biochem Pharmacol 66, 2075-2088, 2003. (Pubitemid 37377853)
16. Williams RJ, Spencer JP, and Rice-Evans C: Flavonoids: antioxidants or signaling molecules? Free Radic Biol Med 36, 838-849, 2004.
17. Vijayababu MR, Arunkumar A, Kanagaraj P, Venkataraman P, Krishnamoorthy G, et al.: Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Mol Cell Biochem 287, 109-116, 2006. (Pubitemid 44057398)
18. Nagini S: Of humans and hamsters: The hamster buccal pouch carcinogenesis model as a paradigm for oral oncogenesis and chemoprevention. Anticancer Agents Med Chem 9, 843-852, 2009.
19. Shklar G: Development of experimental oral carcinogenesis and its impact on current oral cancer research. J Dent Res 78, 1768-1772, 1999.
20. Nagini S, Vidjaya Letchoumy P, Thangavelu A, and Ramachandran CR: Of humans and hamsters: a comparative evaluation of carcinogen activation, DNA damage, cell proliferation, apoptosis, invasion, and angiogenesis in oral cancer patients and hamster buccal pouch carcinomas. Oral Oncol 45, e31-e37, 2009.
21. Legrand-Poels S, Schoonbrodt S, and Piette J: Regulation of interleukin-6 gene expression by pro-inflammatory cytokines in a colon cancer cell line. Biochem J 349, 765-773, 2000. (Pubitemid 30609407)
22. Tanigawa S, Fujii M, and Hou D: Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells. Biosci Biotechnol Biochem 72, 797-804, 2008. (Pubitemid 351463685)
23. Temme A, Rodriguez JA, Hendruschk S, Günes S,Weigle B, et al.: Nuclear localization of survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax. Cancer Lett 250, 177-193, 2007. (Pubitemid 46546648)
24. Yang JH, Hsia TC, Kuo HM, Chao PD, Chou CC, et al.: Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos 34, 296-304, 2006.
25. Psahoulia FH, Drosopoulos KG, Doubravska L, Andera L, and Pintzas A: Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther 6, 2591-2599, 2007. (Pubitemid 47480425)
26. Kim EJ, Choi CH, Park JY, Kang SK, and Kim YK: Flavonoid glycosides isolated from Salicornia herbacea inhibit matrix metalloproteinase in HT1080 cells. Toxicol In Vitro 22, 1742-1748, 2008.
27. Luo H, Jiang BH, King SM, and Chen YC: Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr Cancer 60, 800-809, 2008.
28. Triantafyllou A, Mylonis I, Simos G, Bonanou S, and Tsakalof A: Flavonoids induce HIF-1alpha but impair its nuclear accumulation and activity. Free Radic Biol Med 44, 657-670, 2008.
29. Belinsky SA, Klinge DM, Stidley CA, Issa JP, Herman JG, et al.: Inhibition ofDNAmethylation and histone deacetylation preventsmurine lung cancer. Cancer Res 63, 7089-7093, 2003. (Pubitemid 37413444)
30. Sarkar FH and Li Y: Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics. Cancer Treat Rev 35, 597-607, 2009.
31. Pamukcu AM, Valciner S, Hatcher JF, and Bryan GT: Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinium). Cancer Res 40, 3468-3472, 1980. (Pubitemid 10003733)
32. Gugler R, Leschik M, and Dengler HJ: Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 9, 229-234, 1975.
33. Ito N, Hagiwara A, and Tamano S: Lack of carcinogenicity of quercetin in F344/DuCrj rats. Jpn J Cancer Res 80, 317-325, 1989. (Pubitemid 20035983)
34. Ambrose AM, Robbins DJ, and DeEds F: Comparative toxicities of quercetin and quercetrin. J Am Pharm Assoc 41, 119-122, 1952.
35. Hirono I: Is quercetin carcinogenic? Jpn J Cancer Res 83, 313-314, 1992.
36. Lamson DW and Brignall MS: Antioxidants and cancer III: quercetin. Altern Med Rev 5, 196-208, 2000. (Pubitemid 30419042)